BIG
CLPT icon

Brooklyn Investment Group’s ClearPoint Neuro CLPT Stock Holding History

Brooklyn Investment Group’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-29,289
Closed -$400K – 1876
2025
Q4 		$400K Buy
+29,289
New +$543K 0.02% 833

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Brooklyn Investment Group's CLPT Position: Q1 2026 in Review

Brooklyn Investment Group sold out of ClearPoint Neuro (CLPT) in Q1 2026, closing a stake of 29,289 shares — an estimated $400K sold.

Brooklyn Investment Group first reported a position in CLPT in Q4 2025 and held it in 1 quarter. The position peaked at $400K in Q4 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Brooklyn Investment Group reported no remaining ClearPoint Neuro position as of Q1 2026 after selling out during the quarter.
  • Brooklyn Investment Group sold 29,289 ClearPoint Neuro shares in Q1 2026, an estimated $400K.
  • Brooklyn Investment Group first reported a position in ClearPoint Neuro in Q4 2025 and held it in 1 quarter.
  • Brooklyn Investment Group's ClearPoint Neuro position peaked at $400K in Q4 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.